AAAAAA

   
Results: 1-9 |
Results: 9
COMPARATIVE-STUDY OF INSULIN LISPRO AND REGULAR INSULIN IN PREPUBERTAL CHILDREN WITH TYPE-I DIABETES
Authors: HOLCOMBE JH BRUNELLE R ZALANI S DEEB LC
Citation: Jh. Holcombe et al., COMPARATIVE-STUDY OF INSULIN LISPRO AND REGULAR INSULIN IN PREPUBERTAL CHILDREN WITH TYPE-I DIABETES, Diabetes, 47, 1998, pp. 375-375
PD-103 BRACHYTHERAPY AND EXTERNAL-BEAM IRRADIATION FOR CLINICALLY LOCALIZED, HIGH-RISK PROSTATIC-CARCINOMA
Authors: DATTOLI M WALLNER K SORACE R KOVAL J CASH J ACOSTA R BROWN C ETHERIDGE J BINDER M BRUNELLE R KIRWAN N SANCHEZ S STEIN D WASSERMAN S
Citation: M. Dattoli et al., PD-103 BRACHYTHERAPY AND EXTERNAL-BEAM IRRADIATION FOR CLINICALLY LOCALIZED, HIGH-RISK PROSTATIC-CARCINOMA, International journal of radiation oncology, biology, physics, 35(5), 1996, pp. 875-879
REDUCED FREQUENCY OF HYPOGLYCEMIA WITHOUT LOSS OF GLYCEMIC CONTROL
Authors: ANDERSON J BRUNELLE R PFUETZNER A TRAUTMANN M VIGNATI L
Citation: J. Anderson et al., REDUCED FREQUENCY OF HYPOGLYCEMIA WITHOUT LOSS OF GLYCEMIC CONTROL, Diabetes, 45, 1996, pp. 211-211
REDUCTION OF POSTPRANDIAL GLUCOSE RISE BY INSULIN LISPRO IS INDEPENDENT FROM PREMEAL GLUCOSE VALUES
Authors: TRAUTMANN M BRUNELLE R KOIVISTO V VIGNATI L ANDERSON J
Citation: M. Trautmann et al., REDUCTION OF POSTPRANDIAL GLUCOSE RISE BY INSULIN LISPRO IS INDEPENDENT FROM PREMEAL GLUCOSE VALUES, Diabetes, 45, 1996, pp. 443-443
ASSESSING DIFFERENCES IN THE DISTRIBUTION OF ANTIBODY-FORMATION IN PATIENTS TREATED WITH INSULIN LISPRO AND HUMAN INSULIN USING CLASSICAL AND BAYESIAN MODEL SELECTION TECHNIQUES
Authors: VARSHAVSKY JA ROACH P BRUNELLE R
Citation: Ja. Varshavsky et al., ASSESSING DIFFERENCES IN THE DISTRIBUTION OF ANTIBODY-FORMATION IN PATIENTS TREATED WITH INSULIN LISPRO AND HUMAN INSULIN USING CLASSICAL AND BAYESIAN MODEL SELECTION TECHNIQUES, Diabetes, 45, 1996, pp. 959-959
VALIDATION OF THE DIABETES QUALITY-OF-LIFE CLINICAL-TRIAL QUESTIONNAIRE USING MULTINATIONAL DATA
Authors: SHEN W BRUNELLE R KOTSANOS JG
Citation: W. Shen et al., VALIDATION OF THE DIABETES QUALITY-OF-LIFE CLINICAL-TRIAL QUESTIONNAIRE USING MULTINATIONAL DATA, Quality of life research, 4(6), 1995, pp. 575-575
SAFETY OF [LYS(B28), PRO(B29)] HUMAN INSULIN ANALOG IN LONG-TERM CLINICAL-TRIALS
Authors: ANDERSON J SYMANOWSKI S BRUNELLE R
Citation: J. Anderson et al., SAFETY OF [LYS(B28), PRO(B29)] HUMAN INSULIN ANALOG IN LONG-TERM CLINICAL-TRIALS, Diabetes, 43, 1994, pp. 10000061-10000061
EFFICACY OF [LYS(B28), PRO(B29)] HUMAN INSULIN IN A ONE-YEAR GLOBAL RANDOMIZED CLINICAL-TRIAL
Authors: VIGNATI L ANDERSON J BRUNELLE R
Citation: L. Vignati et al., EFFICACY OF [LYS(B28), PRO(B29)] HUMAN INSULIN IN A ONE-YEAR GLOBAL RANDOMIZED CLINICAL-TRIAL, Diabetes, 43, 1994, pp. 10000078-10000078
[LYS(B28), PRO(B29)] HUMAN INSULIN-(K) - EFFECT OF INJECTION TIME ON GLUCOSE CONTROL
Authors: HOWEY DC ROWE H BRUNELLE R DOWNINGSHELTON J
Citation: Dc. Howey et al., [LYS(B28), PRO(B29)] HUMAN INSULIN-(K) - EFFECT OF INJECTION TIME ON GLUCOSE CONTROL, Diabetes, 42, 1993, pp. 80-80
Risultati: 1-9 |